News | May 22, 2024
AstraZeneca plans $1.5 billion ADCs manufacturing facility in Singapore
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Investing in Malaysia's largest clinic operator to expand the healthcare business
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations
Subscribe To Our Newsletter & Stay Updated
